The Pharmaceutical Research and Manufacturers of America is asking a federal court to revoke the provisions of a recent Medicaid rule that would require manufacturers to include the value of copay assistance in calculations of Medicaid “best prices” unless they can prove that all the assistance goes to patients and not in part to health plans.
The requirement is part of a broader rule issued by the Centers for Medicare and Medicaid Services 31 December...





